Indeed, such non‐apoptotic (non‐canonical) TRAIL activity has been mainly reported in cancer, with TRAIL signaling exerting a pro‐tumorigenic effect in resistant tumor cells 14. The gene discussed is TNFSF10; the disease is cancer.